We are live on ! Find out more
FPF

FNY Partners Fund Portfolio holdings

AUM $185M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+32.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$874M
AUM Growth
-$1.45B
Cap. Flow
+$406M
Cap. Flow %
46.47%
Top 10 Hldgs %
46.76%
Holding
1,634
New
1,030
Increased
183
Reduced
140
Closed
222

Sector Composition

Rank Sector Weight
1 Financials 22.32%
2 Healthcare 18.04%
3 Technology 16.75%
4 Communication Services 11.32%
5 Materials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOLF icon
1301
Wolfspeed
WOLF
$1.34B
$1K ﹤0.01%
+71
New +$1.93K
XHB icon
1302
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.39B
$1K ﹤0.01%
+50
New +$1.78K
XRT icon
1303
PUT
State Street SPDR S&P Retail ETF
XRT
$322M
$1K ﹤0.01%
30
-6
-17% -$258
CBD
1304
DELISTED
Companhia Brasileira de Distribuicao
CBD
$1K ﹤0.01%
100
-8,992
-99% -$166K
MDVL
1305
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1K ﹤0.01%
+1
New +$1.84K
ACER
1306
DELISTED
Acer Therapeutics Inc
ACER
$1K ﹤0.01%
+192
New +$1.89K
TTM
1307
CALL
DELISTED
Tata Motors Limited
TTM
$1K ﹤0.01%
+50
New +$1.83K
CLVS
1308
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
25
+10
+67% +$608
ZNGA
1309
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1K ﹤0.01%
+500
New +$1.34K
MNK
1310
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1K ﹤0.01%
+30
New +$1.48K
NBL
1311
CALL
DELISTED
Noble Energy, Inc.
NBL
$1K ﹤0.01%
+30
New +$1.11K
STML
1312
DELISTED
Stemline Therapeutics, Inc.
STML
$1K ﹤0.01%
+218
New +$1.99K
AGN
1313
PUT
DELISTED
Allergan plc
AGN
$1K ﹤0.01%
+5
New +$1.16K
MDR
1314
CALL
DELISTED
McDermott International
MDR
$1K ﹤0.01%
+64
New +$1.41K
IMPV
1315
CALL
DELISTED
Imperva, Inc.
IMPV
$1K ﹤0.01%
36
LHO
1316
CALL
DELISTED
LaSalle Hotel Properties
LHO
$1K ﹤0.01%
40
TIME
1317
DELISTED
Time Inc.
TIME
$1K ﹤0.01%
+100
New +$1.9K
CBR
1318
DELISTED
CIBER Inc.
CBR
$1K ﹤0.01%
+2,500
New +$1.13K
PLKI
1319
CALL
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$1K ﹤0.01%
+20
New +$1.4K
CLCD
1320
CALL
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$1K ﹤0.01%
+19
New +$822
PTX
1321
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1K ﹤0.01%
+500
New +$1.57K
BTU
1322
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$1K ﹤0.01%
+2,500
New +$1K
REP
1323
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
$1K ﹤0.01%
+100
New +$1K
AAL icon
1324
CALL
American Airlines Group
AAL
$9.03B
-36
Closed -$2K
AAPL icon
1325
PUT
Apple
AAPL
$4.67T
-360
Closed -$10K

Similar funds

FNY Partners Fund's Q1 2017 Portfolio in Review

As of Q1 2017, FNY Partners Fund held 1,634 positions worth $874M, down 62% from $2.32B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

FNY Partners Fund deployed $406M of net new capital in Q1 2017, opening 1,030 new positions and adding to 183 existing holdings. Its largest new stake was Nexstar Media Group: 656,500 shares worth $46.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 1.2% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Procter & Gamble, an estimated $229M trimmed.

  • FNY Partners Fund's largest Q1 2017 buy was Nexstar Media Group: 656,500 shares worth $46.1M.
  • FNY Partners Fund added most to American Capital Ltd in Q1 2017, an estimated $118M increase.
  • FNY Partners Fund's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $229M.
  • FNY Partners Fund fully exited TechnipFMC in Q1 2017, selling an estimated $10.1M.
  • FNY Partners Fund's ten largest holdings make up 47% of its $874M portfolio in Q1 2017.
  • FNY Partners Fund opened 1,030 new positions and closed 222 in Q1 2017.
  • FNY Partners Fund's portfolio value fell 62% quarter-over-quarter to $874M.

Based on FNY Partners Fund's 13F filing for Q1 2017, filed 15 May 2017.